H. Lundbeck A/s

This study is testing an investigational drug called Lu AF82422 to see if it can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder. About 64 participants with MSA will receive either the drug or a placebo for nearly a year to compare th…

This study follows up with patients who received an experimental drug called Lu AG22515 for moderate-to-severe Thyroid Eye Disease. The main goal is to see if the treatment continues to reduce eye bulging over time. Researchers are tracking 20 adults to monitor the drug's long-te…

This large, late-stage trial is testing whether a new drug called amlenetug can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder. About 357 people with MSA will receive either the drug or a placebo via monthly IV infusions for over a y…

This study is testing whether a migraine prevention drug called eptinezumab can help people who still have frequent migraines despite trying other similar preventive medications. It will involve about 150 adults who have at least 8 migraine days per month. The main goal is to see…

This study is testing a new investigational drug called Lu AG09222 to see if it can help prevent migraines. It is for people who have tried 1 to 4 other migraine prevention medications without success. Researchers will compare different doses of the drug against a placebo to find…

This study aims to better understand how Multiple System Atrophy (MSA) progresses over time. Researchers will follow 90 patients in China and Europe, tracking their symptoms and using MRI scans and blood tests to look for biological markers of the disease. The goal is to gather d…